School of Nursing and Midwifery, University of Newcastle, New South Wales, Australia.
Department of Breast Surgery, Zhongshan Hospital Xiamen University, Xiamen, China.
Asian Pac J Cancer Prev. 2021 May 1;22(5):1599-1606. doi: 10.31557/APJCP.2021.22.5.1599.
There are limited data concerning the use of mastectomy and associated factors in China in recent years. This study aimed to investigate the uptake of mastectomy and determine the associations between patients' characteristics and mastectomy among Chinese women with breast cancer.
A retrospective analysis of female breast cancer cases from 1st January 2015 to 31st December 2019 from a tertiary hospital was conducted. Socio-demographic data, clinical data, and surgery types were collected by reviewing the medical record system. Chi-squared test, Fisher's exact test and multivariate logistic regression analysis were used to determine any correlations of patients' characteristics with mastectomy.
A total of 1,171 women with breast cancer were identified, and 76.60% of them underwent a mastectomy. The mastectomy rates showed an increase from 70.62% in 2015 to 86.87% in 2017 and then dropped to 71.91% in 2019. Women undergoing mastectomy were older and were more likely to be married and have at least one child. They had an advanced cancer stage, larger tumour size, and more lymph node invasion and were positive for HER-2 overexpression. Older age, larger tumour size (2-5 cm), higher cancer stages (stage 2- stage 3) and being positive for HER-2 were the four independent variables that significantly predicted the uptake of mastectomy.
Our results showed a wide application of mastectomy in China and uncovered the factors associated with mastectomy uptake from a single-centre experience. Findings suggested the potential overuse of mastectomy among women with early-stage breast cancer, and highlighted the significance of promoting cancer screening in China. Findings could be also used to develop relevant provisions and interventions to facilitate breast cancer treatment decision-making and screening planning.
.
近年来,有关中国乳腺癌患者乳房切除术的应用及相关因素的数据有限。本研究旨在探讨中国女性乳腺癌患者接受乳房切除术的情况,并确定患者特征与乳房切除术之间的关联。
方法:对一家三级医院 2015 年 1 月 1 日至 2019 年 12 月 31 日期间的女性乳腺癌病例进行回顾性分析。通过查阅病历系统收集患者的社会人口统计学数据、临床数据和手术类型。采用卡方检验、Fisher 确切检验和多因素 logistic 回归分析来确定患者特征与乳房切除术之间的相关性。
结果:共纳入 1171 例乳腺癌患者,其中 76.60%的患者接受了乳房切除术。乳房切除术的比例从 2015 年的 70.62%增加到 2017 年的 86.87%,然后在 2019 年降至 71.91%。接受乳房切除术的患者年龄较大,更有可能已婚且至少育有一个孩子。她们的癌症分期较晚,肿瘤较大,淋巴结侵犯较多,HER-2 过表达阳性。多因素 logistic 回归分析结果显示,年龄较大、肿瘤较大(2-5cm)、癌症分期较高(Ⅱ期-Ⅲ期)和 HER-2 阳性是预测乳房切除术的四个独立变量。
结论:我们的研究结果表明,在中国广泛应用了乳房切除术,并从单中心经验中揭示了与乳房切除术使用率相关的因素。结果提示,在中国早期乳腺癌患者中存在乳房切除术过度应用的潜在风险,强调了在中国开展癌症筛查的重要性。研究结果还可用于制定相关规定和干预措施,以促进乳腺癌治疗决策和筛查计划。